Persistence of Candida species in the respiratory tract of cystic fibrosis patients

References

• Burns JL, Van Dalfsen JM, Shawar RM, . Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis J Infect Dis 1999; 179:1190–1196.
   PubMed Web of Science ®Google Scholar
• Galant SP, Rucker RW, Groncy CE, Wells ID, Novey HS. Incidence of serum antibodies to several Aspergillus species and to Candida albicans in cystic fibrosis. Am Rev Respir Dis 1976; 114:325–331.
   PubMed Web of Science ®Google Scholar
• Peltroche-Llacsahuanga H, Dohmen H, Haase G. Recovery of Candida dubliniensis from sputum of cystic fibrosis patients. Mycoses 2002; 45:15–18.
   PubMed Web of Science ®Google Scholar
• Staib P, Morschhauser J. Chlamydospore formation on Staib agar as a species-specific characteristic of Candida dubliniensis. Mycoses 1999; 42:521–524.
   PubMed Web of Science ®Google Scholar
• CLSI. National Committee for Clinical Laboratory Standards: Reference method for broth dilution antifungal susceptibility testing of yeasts: approved standard M27-A. Wayne PA: National Committee for Clinical Laboratory Standards. 2002.
   Google Scholar
• Muller FM, Kurzai O, Hacker J, Frosch M, Muhlschlegel F. Effect of the growth medium on the in vitro antifungal activity of micafungin (FK-463) against clinical isolates of Candida dubliniensis. J Antimicrob Chemother 2001; 48:713–715.
   PubMed Web of Science ®Google Scholar
• Lasker BA, Page LS, Lott TJ, Kobayashi GS. Isolation, characterization, and sequencing of Candida albicans repetitive element 2. Gene 1992; 116:51–57.
   PubMed Web of Science ®Google Scholar
• Ruhnke M, Schmidt-Westhausen A, Morschhauser J. Development of simultaneous resistance to fluconazole in Candida albicans and Candida dubliniensis in a patient with AIDS. J Antimicrob Chemother 2000; 46:291–295.
   Google Scholar
• Gil-Lamaignere C, Roilides E, Hacker J, Muller FM. Molecular typing for fungi – a critical review of the possibilities and limitations of currently and future methods. Clin Microbiol Infect 2003; 9:172–185.
   PubMed Web of Science ®Google Scholar
• Lischewski A, Harmsen D, Wilms K, . Molecular epidemiology of Candida albicans isolates from AIDS and cancer patients using a novel standardized CARE-2 DNA fingerprinting technique. Mycoses 1999; 42:371–383.
   Google Scholar
• Schmid J, Odds FC, Wiselka MJ, Nicholson KG, Soll DR. Genetic similarity and maintenance of Candida albicans strains from a group of AIDS patients, demonstrated by DNA fingerprinting. J Clin Microbiol 1992; 30:935–941.
   PubMed Web of Science ®Google Scholar
• Reiss E, Tanaka K, Bruker G, . Molecular diagnosis and epidemiology of fungal infections. Med Mycol 1998; 36:(Suppl. 1):249–257.
   Google Scholar
• Doern GV, Brogden-Torres B. Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis. J Clin Microbiol 1992; 30:2740–2742.
   PubMed Web of Science ®Google Scholar
• Kerkmann ML, Schuppler M, Paul KD, Schoenian G, Smith MT. Red-pigmented Candida albicans in patients with cystic fibrosis. J Clin Microbiol 1999; 37:278.
   Google Scholar
• Bauernfeind A, Bertele RM, Harms K, . Qualitative and quantitative microbiological analysis of sputa of 102 patients with cystic fibrosis. Infection 1987; 15:270–277.
   PubMed Web of Science ®Google Scholar
• Franz R, Kelly SL, Lamb DC, . Multiple molecular mechanisms contribute to a stepwise development of fluconazole resistance in clinical Candida albicans strains. Antimicrob Agents Chemother 1998; 42:3065–3072.
   PubMed Web of Science ®Google Scholar
• Przyklenk B, Bauernfeind A, Horl G, Emminger G. Serologic response to Candida albicans and Aspergillus fumigatus in cystic fibrosis. Infection 1987; 15:308–310.
   Google Scholar
• Muller FM, Kasai M, Francesconi A, . Transmission of an azole-resistant isogenic strain of Candida albicans among human immunodeficiency virus-infected family members with oropharyngeal candidiasis. J Clin Microbiol 1999; 37:3405–3408.
   Google Scholar
• Magaldi S, Mata S, Hartung C, . In vitro susceptibility of 137 Candida sp. isolates from HIV positive patients to several antifungal drugs. Mycopathologia 2001; 149:63–68.
   Google Scholar
• Quindos G, Carrillo-Munoz AJ, Arevalo MP, . In vitro susceptibility of Candida dubliniensis to current and new antifungal agents. Chemotherapy 2000; 46:395–401.
   PubMed Web of Science ®Google Scholar
• Melo AS, de Almeida LP, Colombo AL, Briones MR. Evolutionary distances and identification of Candida species in clinical isolates by randomly amplified polymorphic DNA (RAPD). Mycopathologia 1998; 142:57–66.
   PubMedGoogle Scholar
• Steffan P, Vazquez JA, Boikov D, . Identification of Candida species by randomly amplified polymorphic DNA fingerprinting of colony lysates. J Clin Microbiol 1997; 35:2031–2039.
   PubMed Web of Science ®Google Scholar
• Araj GF, Daher NK, Tabbarah ZA. Antifungal susceptibility of Candida isolates at the American University of Beirut Medical Center. Int J Antimicrob Agents 1998; 10:291–296.
   Google Scholar
• St-Germain G, Laverdiere M, Pelletier R, . Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996 and 1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 2001; 39:949–953.
   PubMed Web of Science ®Google Scholar
• Smith WL, Edlind TD. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation. Antimicrob Agents Chemother 2002; 46:3532–3539.
   PubMed Web of Science ®Google Scholar
• Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46:1773–1780.
   PubMed Web of Science ®Google Scholar
• Abruzzo GK, Flattery AM, Gill CJ, . Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob Agents Chemother 1997; 41:2333–2338.
   PubMed Web of Science ®Google Scholar
• Mora-Duarte J, Betts R, Rotstein C, . Comparison of caspofungin and amphotericin B for invasive candidiasis. N Engl J Med 2002; 347:2020–2029.
   PubMed Web of Science ®Google Scholar